- Injective price is extending gains above the $10 mark.
- Bitcoin’s rally above $105k and real-world assets tokenization catalysts could drive the INJ price higher.
- INJ technical outlook is largely bullish.
Injective (INJ) is among the top-performing altcoins on Monday as bullish sentiment sweeps through the cryptocurrency market.
The token is trading above $13.60, lifted by renewed investor confidence following Bitcoin’s surge past $105,000.
With macroeconomic optimism and progress on regulatory fronts driving broader market momentum, analysts suggest Bitcoin could challenge new all-time highs in the near term.
This backdrop is fuelling capital rotation into altcoins, with projects like Injective benefiting from increased speculative interest.
A layer-1 blockchain focused on decentralised finance and real-world asset tokenization, Injective has continued to attract attention as narratives around scalability and use-case-driven growth gain ground.
Injective price extends gains above $10
Injective (INJ) price is up 7% in the past 24 hours, gaining as top alts such as Ethereum, BNB, and Solana break to key levels.
The price of INJ has surged after recently breaking past the $10 mark.
Currently, it changes hands for around $13.62. However, it hovered at highs of $14.29 on May 12, 2025, to hit its highest level since late February.
Amid the price gains, Injective’s market cap rose to $1.37 billion, although the 24-hour trading volume remained modest at $172 million.
Having surged 46% in seven days and 67% in the last 30 days, the overall market interest might see bulls take control.
Bitcoin rally and RWA tokenization drive INJ price
While Bitcoin’s rally is fueling further optimism across the market, catalysts for INJ price also include strong institutional demand across its RWA ecosystem.
Tokenization is a key tailwind for Injective, with a recent Four Pillars report highlighting how this sector is shaping up INJ for traction.
Recent bull cycles have had DeFi, play-to-earn games, memecoins, and AI tokens explode.
Now, analysts say while these areas see growth, the RWA market’s growth has blockchains like Injective in the spotlight.
Injective’s network, optimized for the tokenization of traditional assets like stocks, stablecoins, and commodities, stands as a likely beneficiary.
Investors eyeing an on-chain opportunity are increasingly seeing it as the go-to platform.
RWA adoption may further boost INJ’s price momentum.
Injective price technical outlook
From a technical perspective, INJ’s daily chart paints a bullish picture.
INJ chart by TradingView
The daily Relative Strength Index (RSI) currently hovers in overbought territory.
However, it’s not overly extended to suggest more room for bulls.
If it sees a pullback, INJ will likely bounce off support around $11.05 and $10.22.
This scenario may align with the Moving Average Convergence Divergence (MACD), which shows a bullish crossover.
The histogram indicates an upward momentum. If this happens, bulls will target $16 and then $20.
